Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Neoplasms, Plasma Cell 1Neoplasm, Residual 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Leukemia, Plasma Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Chromosome 17 deletion 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dexamethasone 2liposomal doxorubicin 1fludarabine phosphate 1fludarabine 1Melphalan 1Maintenance 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Plasma Cell × Maintenance × Clear all
NCT04008888 2019-07-05

a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Unknown
50 enrolled
Other hematologic neoplasmPlasma cell

Chromosome 17 deletion, Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡